0001225208-21-006242.txt : 20210401 0001225208-21-006242.hdr.sgml : 20210401 20210401191112 ACCESSION NUMBER: 0001225208-21-006242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210401 DATE AS OF CHANGE: 20210401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lemercier Jean-Luc M CENTRAL INDEX KEY: 0001710625 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 21800006 MAIL ADDRESS: STREET 1: C/O ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edwards Lifesciences Corp CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP. DATE OF NAME CHANGE: 20090225 FORMER COMPANY: FORMER CONFORMED NAME: EDWARDS LIFESCIENCES CORP DATE OF NAME CHANGE: 20000203 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 doc4.xml X0306 4 2021-04-01 0001099800 Edwards Lifesciences Corp EW 0001710625 Lemercier Jean-Luc M ONE EDWARDS WAY IRVINE CA 92614 1 CVP, EMEA, Canada, Latin Amer Common Stock 2021-04-01 4 M 0 13020.0000 13.9800 A 152561.1380 D Common Stock 2021-04-01 4 S 0 13020.0000 83.6608 D 139541.1380 D Employee Stock Option (Right to Acquire) 13.9800 2021-04-01 4 M 0 13020.0000 0.0000 D 2015-05-08 2021-05-07 Common Stock 13020.0000 0.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 23, 2020. This transaction was executed in multiple trades at prices ranging from $83.1600 to $84.0000. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan. Linda J. Park, Attorney-in-Fact 2021-04-01